Preliminary
Biomarkers — Aging clocks and measurement tools
Review / Commentary
PubMed
This explains why no single anti-aging drug works for everyone: aging involves many interconnected systems, not one master switch.
Proposes multilevel network model of aging with partially autonomous processes and regulatory hubs, explaining why single-target interventions yield tissue-specific, partial effects rather than uniform rejuvenation.
This paper argues that biological aging isn't driven by a single master mechanism, but rather by multiple partially independent processes linked through a network of regulatory hubs. This framework explains why anti-aging treatments typically produce …
Biogerontology